SOPH Q4 2021 Earnings — SOPHiA GENETICS S.A. Revenue & Financial Results | Market Cap Arena

SOPHSOPHiA GENETICS S.A.

$308M

Q4 2021 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$11M+39.6% YoY

Gross Profit

$7M62.4% margin

Operating Income

-$21M-192.1% margin

Net Income

-$21M-195.4% margin

EPS (Diluted)

$-0.36

QoQ Revenue Growth

+5.6%

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$17M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$320M

Total Liabilities

$45M

Stockholders' Equity

$275M

Cash & Equivalents

$193M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$8M	+39.6%
Gross Profit	$7M	$5M	+39.7%
Operating Income	-$21M	-$11M	-86.1%
Net Income	-$21M	-$10M	-103.9%